Health Desk – 17 Mar,2021: Worldwide distribution of AstraZeneca’s COVID-19 vaccine remains unaffected by the jab’s suspension in much of Europe following reports of blood clots in some people shortly after vaccination, the World Health Organization (WHO) said, reported The Washington Post.
The number of blood clots reported was not higher than what would be expected in a given population.
Australia announced March 16 that it would continue to use the vaccine.
“We are aware of some further European countries pausing the use of the AstraZeneca vaccine due to reports of blood clots in people who have been vaccinated,” Australian Chief Medical Officer Dr. Paul Kelly said in a statement.
“While the European Medicines Agency is investigating these events, it has reinforced its view that the AstraZeneca COVID-19 vaccine is successful in protecting against COVID-19 and should continue to be used in the rollout,” he added.
According to the Post, WHO continues to caution against suspending access to vaccines and has also noted that no evidence links these events to the AstraZeneca COVID-19 vaccine.
